Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelatin sponge impregnated with calcitonin to reduce pain and dry socket after mandibular molar extraction
IRCT20240901062929N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of TBRIA in postoperative pain and alveolar osteitis (AO), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Post-extraction pain intensity and Incidence of dry socket (alveolar osteitis). Started Jan 2025; status: completed.
02
Drugs
TBRIA
03
Conditions
postoperative painalveolar osteitis (AO)
Beyond the preview
Go deeper on IRCT20240901062929N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240901062929N1.